Inventor · disambiguated record
Ching-Juh Lai
Also filed as: LAI CHING-JUH
29 granted patents·3 pending applications·293 citations·filing 1994–2024
96Inventor score
Files withUS HEALTH11THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES5GONCALVEZ ANA P3THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES2US GOVERNMENT2
Top patents by PatentIndex Score
32 records- 0194USRE46042EDevelopment of dengue virus vaccine componentsUS GOVERNMENT·Filed 2007·Granted Jun 28, 2016·8 cites·14 claims
- 0292US6184024B1Chimeric and/or growth-restricted flavivirusesUS HEALTH·Filed 1994·Granted Feb 6, 2001·140 cites·52 claims
- 0392US2025236848A1Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 0491US9090873B2Development of dengue virus vaccine componentsUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2012·Granted Jul 28, 2015·5 cites·19 claims
- 0591US8632782B2Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated regionWHITEHEAD STEPHEN S·Filed 2011·Granted Jan 21, 2014·10 cites·17 claims
- 0689US12203100B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jan 21, 2025·0 cites·3 claims
- 0789US6676936B1Chimeric and/or growth-restricted flavivirusesUS HEALTH·Filed 2000·Granted Jan 13, 2004·25 cites·5 claims
- 0888USRE46631EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 12, 2017·7 cites·42 claims
- 0988US6497884B1Chimeric vaccine against tick-borne encephalitis virusUS HEALTH·Filed 2000·Granted Dec 24, 2002·24 cites·9 claims
- 1087US6660273B2Chimeric vaccine against tick-borne encephalitis virusUS HEALTH·Filed 2002·Granted Dec 9, 2003·20 cites·10 claims
- 1186US7622113B2Monoclonal antibodies that bind or neutralize dengue virusUS HEALTH·Filed 2004·Granted Nov 24, 2009·18 cites·26 claims
- 1285USRE46641EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 19, 2017·5 cites·36 claims
- 1385US9783787B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2011·Granted Oct 10, 2017·5 cites·9 claims
- 1485USRE45016EDevelopment of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2013·Granted Jul 15, 2014·4 cites·13 claims
- 1585US8337853B2Monoclonal antibodies that bind or neutralize dengue virusLAI CHING-JUH·Filed 2009·Granted Dec 25, 2012·7 cites·25 claims
- 1684US9707287B2Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural proteinTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Jul 18, 2017·3 cites·17 claims
- 1784US8337854B2Monoclonal antibodies against dengue and other viruses with deletion in Fc regionGONCALVEZ ANA P·Filed 2008·Granted Dec 25, 2012·8 cites·16 claims
- 1883US11746335B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2022·Granted Sep 5, 2023·0 cites·4 claims
- 1982USRE45053EAttenuated dengue virus comprising mutations in the NS3 geneUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH WASHINGTON D C·Filed 2013·Granted Jul 29, 2014·4 cites·16 claims
- 2080US11318196B2Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural proteinUS HEALTH·Filed 2019·Granted May 3, 2022·0 cites·16 claims
- 2176US11753627B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4US HEALTH·Filed 2020·Granted Sep 12, 2023·0 cites·4 claims
- 2274US11332722B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted May 17, 2022·0 cites·6 claims
- 2372US10837003B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4US HEALTH·Filed 2017·Granted Nov 17, 2020·0 cites·5 claims
- 2471US10724007B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Jul 28, 2020·0 cites·9 claims
- 2568US10500264B2Development of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS HEALTH·Filed 2017·Granted Dec 10, 2019·0 cites·13 claims
- 2666US10160957B2Development of dengue virus vaccine componentsUS HEALTH·Filed 2015·Granted Dec 25, 2018·0 cites·6 claims
- 2766USRE45123ERecombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesisUS GOVERNMENT·Filed 2013·Granted Sep 9, 2014·0 cites·10 claims
- 2862US8506961B2Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their useGONCALVEZ ANA P·Filed 2009·Granted Aug 13, 2013·0 cites·33 claims
- 2960US2013089543A1Monoclonal antibodies that bind or neutralize dengue virusUSA AS REPRESENTED BY THE SECRETARY DEPT·Filed 2012·Application pending·0 cites
- 3052US9783596B2Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their useUS HEALTH·Filed 2016·Granted Oct 10, 2017·0 cites·24 claims
- 3151US9273121B2Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their useUS SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2013·Granted Mar 1, 2016·0 cites·19 claims
- 3249US2013344058A1Monoclonal antibodies against dengue and other viruses with deletion in fc regionGONCALVEZ ANA P·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ching-Juh Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →